ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced its second Japanese Patent.

Azenta Life Sciences has selected Oxford, UK, a key European life sciences hub, as the location for its next GENEWIZ Multiomics and Synthesis Solutions site. The site will feature a new state-of-the-art genomics lab scheduled to open in early 2024.

The companies are working together on next-generation technology in the fast-growing field of synthetic biology. This new technology will improve the quality, speed, and cost of developing synthetic biological solutions such as life-saving vaccines.

AMSBIO announce the launch of a custom service providing access to a suite of powerful spatial biology multi-omics profiling tools.

Yourgene’s LightBench® instrument offers precise and accurate size selection of PacBio® SMRTbell® sequencing libraries increasing HiFi sequencing yields.

Oxford Nanopore, and Day Zero Diagnostics (DZD), announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.